Volume 20, Issue 108 (6-2013)                   RJMS 2013, 20(108): 11-19 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Morvaridi A, Delirezh N, Hobbenaghi R, Abtahi Froushani S M, Malekinejad H. The effects of All-Trans Retinoic Acid on clinical symptoms, nitric oxide levels and total antioxidant capacity of plasma in mouse model of multiple sclerosis. RJMS 2013; 20 (108) :11-19
URL: http://rjms.iums.ac.ir/article-1-2573-en.html
Urmia University
Abstract:   (7312 Views)

  Background: In recent years, increasing evidence suggest that free radicals plays an important role in the pathogenesis of multiple sclerosis and Experimental Autoimmune Encephalomyelitis (EAE), an animal model of multiple sclerosis. Therefore, All-Trans Retinoic Acid (ATRA) as an antioxidant may be effective in ameliorating disease severity.

  Methods : The present research is an experimental-interventional study . EAE was induced by immunization of female C57BL/6 mice with MOG35-55 peptide and complete Freund's adjuvant. EAE mice were placed in two therapeutic groups (n=7 per group).Also, 7 mice served as normal (non-EAE) controls. Treatment with ATRA (25mg/Kg-every other day) was initiated in treatment group at day 12 when the treatment group developed a disability score. EAE control received vehicle alone with same schedule. Signs of disease were recorded daily until the day 33 when mice were sacrificed. Then, the levels of nitric oxide in spleen cell culture supernatant and total antioxidant capacity of plasma in mice were evaluated.

  Results: ATRA significantly alleviated the clinical signs of established EAE. Upon antigen-specific re-stimulation of splenocytes, nitric oxide production was significantly reduced in TRA-treated group and reached in the range of normal mice. In addition, reduction in antioxidant capacity of serum in ATRA-treated EAE mice was prevented.

  Conclusions: At least part of the beneficial effects of ATRA in the treatment of EAE may be done by suppressing nitric oxide levels and improving antioxidant defense potential.

Full-Text [PDF 388 kb]   (2834 Downloads)    
Type of Study: Research | Subject: immunopatology

Add your comments about this article : Your username or Email:

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Razi Journal of Medical Sciences

Designed & Developed by : Yektaweb